Global Burden of Leptospirosis: Estimated in Terms of Disability Adjusted Life Years
- PMID: 26431366
- PMCID: PMC4591975
- DOI: 10.1371/journal.pntd.0004122
Global Burden of Leptospirosis: Estimated in Terms of Disability Adjusted Life Years
Abstract
Background: Leptospirosis, a spirochaetal zoonosis, occurs in diverse epidemiological settings and affects vulnerable populations, such as rural subsistence farmers and urban slum dwellers. Although leptospirosis can cause life-threatening disease, there is no global burden of disease estimate in terms of Disability Adjusted Life Years (DALYs) available.
Methodology/principal findings: We utilised the results of a parallel publication that reported global estimates of morbidity and mortality due to leptospirosis. We estimated Years of Life Lost (YLLs) from age and gender stratified mortality rates. Years of Life with Disability (YLDs) were developed from a simple disease model indicating likely sequelae. DALYs were estimated from the sum of YLLs and YLDs. The study suggested that globally approximately 2.90 million DALYs are lost per annum (UIs 1.25-4.54 million) from the approximately annual 1.03 million cases reported previously. Males are predominantly affected with an estimated 2.33 million DALYs (UIs 0.98-3.69) or approximately 80% of the total burden. For comparison, this is over 70% of the global burden of cholera estimated by GBD 2010. Tropical regions of South and South-east Asia, Western Pacific, Central and South America, and Africa had the highest estimated leptospirosis disease burden.
Conclusions/significance: Leptospirosis imparts a significant health burden worldwide, which approach or exceed those encountered for a number of other zoonotic and neglected tropical diseases. The study findings indicate that highest burden estimates occur in resource-poor tropical countries, which include regions of Africa where the burden of leptospirosis has been under-appreciated and possibly misallocated to other febrile illnesses such as malaria.
Conflict of interest statement
The authors either served as members of the World Health Organization advisory body—the Leptospirosis Burden Epidemiology Reference Group or acted as advisors to LERG—without remuneration. The authors declare no other competing interests.
Figures




Similar articles
-
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.Lancet. 2024 May 18;403(10440):2133-2161. doi: 10.1016/S0140-6736(24)00757-8. Epub 2024 Apr 17. Lancet. 2024. PMID: 38642570 Free PMC article.
-
Global burden associated with 85 pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019.Lancet Infect Dis. 2024 Aug;24(8):868-895. doi: 10.1016/S1473-3099(24)00158-0. Epub 2024 Apr 16. Lancet Infect Dis. 2024. PMID: 38640940 Free PMC article.
-
The burden of Neglected Tropical Diseases in Brazil, 1990-2016: A subnational analysis from the Global Burden of Disease Study 2016.PLoS Negl Trop Dis. 2018 Jun 4;12(6):e0006559. doi: 10.1371/journal.pntd.0006559. eCollection 2018 Jun. PLoS Negl Trop Dis. 2018. PMID: 29864133 Free PMC article.
-
Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.Lancet Psychiatry. 2022 Feb;9(2):137-150. doi: 10.1016/S2215-0366(21)00395-3. Epub 2022 Jan 10. Lancet Psychiatry. 2022. PMID: 35026139 Free PMC article.
-
Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010.Lancet. 2013 Nov 9;382(9904):1575-86. doi: 10.1016/S0140-6736(13)61611-6. Epub 2013 Aug 29. Lancet. 2013. PMID: 23993280 Review.
Cited by
-
Tropical Co-infection in a Tertiary Care Center in South India: A Case Report.Cureus. 2024 Aug 22;16(8):e67487. doi: 10.7759/cureus.67487. eCollection 2024 Aug. Cureus. 2024. PMID: 39310443 Free PMC article.
-
Leptospiral adhesins: from identification to future perspectives.Front Microbiol. 2024 Aug 13;15:1458655. doi: 10.3389/fmicb.2024.1458655. eCollection 2024. Front Microbiol. 2024. PMID: 39206373 Free PMC article. Review.
-
Gene expression is associated with virulence in murine macrophages infected with Leptospira spp.PLoS One. 2019 Dec 4;14(12):e0225272. doi: 10.1371/journal.pone.0225272. eCollection 2019. PLoS One. 2019. PMID: 31800570 Free PMC article.
-
Health Challenges of the Pacific Region: Insights From History, Geography, Social Determinants, Genetics, and the Microbiome.Front Immunol. 2019 Sep 13;10:2184. doi: 10.3389/fimmu.2019.02184. eCollection 2019. Front Immunol. 2019. PMID: 31572391 Free PMC article. Review.
-
Distribution, frequency and clinical presentation of leptospirosis and coinfections: a systematic review protocol.BMJ Open. 2022 Dec 16;12(12):e055187. doi: 10.1136/bmjopen-2021-055187. BMJ Open. 2022. PMID: 36526310 Free PMC article.
References
-
- Bharti AR, Nally JE, Ricaldi JN, Matthias MA, Diaz MM, Lovett MA, et al. Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis. 2003;3: 757–771. - PubMed
-
- Pappas G, Papadimitriou P, Siozopoulou V, Christou L, Akritidis N. The globalization of leptospirosis: worldwide incidence trends. Int J Infect Dis IJID Off Publ Int Soc Infect Dis. 2008;12: 351–357. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical